Romosozumab

Indication

Severe osteoporosis (NICE TA791)

Red

Brand:

Nice TA:

791

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:

Endocrine system

1.1 Romosozumab is recommended as an option for treating severe osteoporosis in people after menopause who are at high risk of fracture, only if:

they have had a major osteoporotic fracture (spine, hip, forearm or humerus fracture) within 24 months (so are at imminent risk of another fracture) and
the company provides romosozumab according to the commercial arrangement.

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

BwD	BP	CSR	EL	FW	GP	MB	WL
Red	Red	Red	Red	Red	Red	Red	Red

What do the colours mean?

Last Updated: 15 - Jul - 2022